Orion 10

STUDY IDENTIFIER:

ORION 10

CONDITION:

Hypercholesterolemia

CONTACT INFO:

Laura Onstot   |   laura.onstot@allina.com   |   612-863-6120

DESCRIPTION:

A Placebo-Controlled, Double-Blind, Randomized Trial to Evaluate the Effect of 300mg of Inclisiran Sodium Given as Subcutaneous Injections in Subjects with Atherosclerotic Cardiovascular Disease (ASCVD) and Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

CRITERIA LIST/ QUALIFICATIONS:

  • 18 or older
  • history of cardiovascular disease
  • LDL >70
  • Triglycerides < 400
  • On max tolerated statin therapy (can be statin intolerant)

INVESTIGATORS:

Thomas Knickelbine, MD

SPONSORS:

The Medicines Company

STATUS:

Open/Enrolling

Support the research and educational efforts of MHIF

Make a Donation